|
 This site complies with the HONcode standard for trustworthy health information: verify here.
Rewarding for you and us Defeat Diabetes Foundation
Defeat Diabetes Foundation 150 153rd Ave, Suite 300 Madeira Beach, FL 33708
|
Research » Drugs
Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.
The Next DPP-4 Inhibitor Onglyza™ Passes CVD Review: Coming Soon
Posted: Wednesday, April 15, 2009
|
An FDA panel voted 10-2 that the investigational diabetes drug saxagliptin (Onglyza) does not put Type 2 diabetes patients at an increased risk for cardiovascular events, but wants drugmaker Bristol-Myers Squibb to conduct long-term postmarketing studies to test the drug in older and sicker patients.
|
Olive Oil Compound Protects Against Heart Disease
Posted: Saturday, April 11, 2009
|
Already known to have general antioxidant properties, a specific antioxidant compound within olive oil has recently been identified, that may explain why people whose diets are high in olive oil have a lower incidence of cardiovascular disease (CVD).
|
New Link Between Obesity and Insulin Resistance Uncovered
Posted: Saturday, April 11, 2009
|
The high BCAA protein levels found in obese individuals, combined with high fat diets, could significantly increase the incidence of pre-diabetic insulin resistance. Because obesity and diabetes are so closely linked, this finding could go a long way in explaining the cause and effect of the obesity-diabetes connection, as well as lay the foundations for future preventative treatments for diabetes in obese individuals.
|
Brown Fat Could Help Treat Obesity and Diabetes
Posted: Friday, April 10, 2009
|
Brown fat, which helps use energy and burn calories, and was previously believed to only to exist in babies, has recently been shown to occur in adults as well. The discovery of the presence of this "good fat" in adults lays foundations for potential obesity and diabetes treatments that stimulate brown fat growth.
|
Two New Diabetes Drugs could be Approved by April 2nd
Posted: Thursday, March 26, 2009
|
A U.S. Food and Drug Administration panel will review two proposed drugs to treat Type 2 diabetes this April. According to a meeting notice posted on the FDA's website Monday, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee will discuss Bristol-Myers Squibb's saxagliptin tablets on April 1 and Novo Nordisk.'s liraglutide injection on April 2.
|
Bariatric Surgery Causes Most Cases of Type 2 to Remit Long-Term
Posted: Thursday, March 26, 2009
|
In morbidly obese patients with Type 2 diabetes, bariatric surgery leads to resolution or improvement of the disease in close to 90% of cases, with benefits usually maintained for at least 2 years, according to a meta-analysis.
|
FDA Announces New Recommendations on Evaluating Cardiovascular Risk in Drugs Intended to Treat Type 2 Diabetes
Posted: Thursday, March 26, 2009
|
The FDA recommended that manufacturers developing new drugs and biologics for Type 2 diabetes provide evidence that the therapy will not increase the risk of such cardiovascular events as a heart attack. The recommendation is part of a new guidance for industry that applies to all diabetes drugs currently under development.
|
Diabetes Cost Calculator Tool Calculates Savings to Employers for Better Diabetes Management
Posted: Thursday, March 26, 2009
|
AHRQ has a new tool that is designed to help employers better estimate how to save money while still paying health care costs for employees who have diabetes.
|
Diabetic Cystic Fibrosis Patients Effected by "Superbug"
Posted: Sunday, March 22, 2009
|
A common procedure to treat cystic fibrosis (CF), in which a specific type of sugar is inhaled into the lungs, might lead to dangerous complications, especially for diabetics. A bacteria, known as burkholderia cepacia complex (Bcc), appears to create further mucus buildup for CF patients as a result of this procedure, and has been labeled a "superbug."
|
Self-Donated Stem Cells Help Diabetics
Posted: Wednesday, March 18, 2009
|
Autologous stem cell (ASC) infusions appear to greatly improve glycemic control in diabetics. The benefits of the procedure were further enhanced through hyperbaric oxygen (HBO) treatment, before and after. The findings give some promise to a disease (specifically, type 2 diabetes) that is a growing worldwide problem, and has no known cure.
|
|
Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.
 Send your unopened, unexpired test strips to:
Defeat Diabetes Foundation 150 153rd Ave, Suite 300 Madeira Beach, FL 33708

DDF advertisement

Friendly Banner
Friendly Banner
Analyze nutrition content by portion DDF advertisement
|